Small molecule therapy(Evommune/Accutar Biotechnology)

N/A

Report date: 2024/01/29 15:01:11

Base Information

Drug NameSmall molecule therapy(Evommune/Accutar Biotechnology)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEvommune IncAccutar Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesEvommune IncAccutar Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A